...
首页> 外文期刊>Tumour biology : >miR-145 inhibits invasion and metastasis by directly targeting Smad3 in nasopharyngeal cancer
【24h】

miR-145 inhibits invasion and metastasis by directly targeting Smad3 in nasopharyngeal cancer

机译:miR-145通过直接靶向Smad3抑制鼻咽癌的侵袭和转移

获取原文
获取原文并翻译 | 示例

摘要

MicroRNA-145 (miR-145) has been implicated in several cancers. However, its role in nasopharyngeal carcinoma (NPC) remains unclear. In this study, we proved that miR-145 was significantly downregulated in NPC and associated with NPC cell metastasis. Moreover, miR-145 suppressed Smad3 by directly binding to the 3'-untranslated region (UTR) of Smad3. Knockdown of Smad3 in NPC cells inhibited cell migration and invasion, which was consistent with the effect of miR-145 in NPC cells. In addition, Smad3 expression was inversely correlated with miR-145 level in clinical NPC samples. Taken together, our findings indicate that miR-145 is a tumour suppressor that affects invasive and metastatic properties of NPC via the miR-145/Smad3 axis, leading us to propose that miR-145 overexpression might be a potential therapeutic strategy of NPC intervention.
机译:MicroRNA-145(miR-145)与多种癌症有关。然而,其在鼻咽癌(NPC)中的作用尚不清楚。在这项研究中,我们证明了miR-145在NPC中显着下调并与NPC细胞转移有关。此外,miR-145通过直接结合Smad3的3'-非翻译区(UTR)抑制Smad3。在NPC细胞中抑制Smad3抑制了细胞迁移和侵袭,这与miR-145在NPC细胞中的作用是一致的。此外,临床NPC样品中Smad3表达与miR-145水平成反比。综上所述,我们的发现表明miR-145是一种肿瘤抑制因子,它通过miR-145 / Smad3轴影响NPC的侵袭和转移特性,从而使我们提出miR-145过表达可能是NPC干预的潜在治疗策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号